Navigation Links
Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference
Date:1/4/2012

candidate utilizing the Company's novel Ii-Key Hybrid technology platform is a HER-2/neu Peptide Vaccine (AE37).  This "off-the-shelf" cancer immunotherapy product candidate is easier and less costly to produce than comparable cell-based approaches.  AE37 is derived from a peptide fragment of the human epidermal growth factor receptor 2 (HER2) oncoprotein, which is expressed in a variety of tumors including 75-80% of breast cancers as well as a high percentage of prostate, ovarian and other cancers.  AE37 represents the only HER2-based peptide vaccine currently being studied in a randomized trial and its use is not restricted to patients with a particular type of human leukocyte antigen (HLA) peptide.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases.  Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy.  One of its platform technologies relies on inhibition of expression of the Ii protein.  Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells.  For more information, visit the Generex website at

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... IRVINE, Calif. , Aug. 31, 2015 /PRNewswire/ ... business and government, where regulations are often strict ... environment is driving a demand for professionals who ... interpret these regulations across a product lifecycle and ... organization. The University of California, Irvine Extension ...
(Date:8/31/2015)... FLINT, Mich. , Aug. 31, 2015  Diplomat Pharmacy, ... pharmacy, has announced that Phil Hagerman , Chairman & ... four upcoming investor conferences. Mr. Hagerman and ... 2015 Healthcare Conference in Boston on ... Mr. Hagerman and Mr. Whelan are also scheduled to participate ...
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated ... subsidiary, Qualcomm Life, Inc., is collaborating ... chronic care management solutions powered by Qualcomm Life,s ... Platform to enable continuous care, informed interventions and ... announced at Qualcomm Life,s annual Connect 2015 ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 2011 Reportlinker.com announces that a new market research ... Global Injectable Drug Delivery Market (2010 - 2015) ... KEY TAKE AWAYS * To ... its various sub-segments with respect to types of systems, ...
... Reportlinker.com announces that a new market research report ... European Markets for Minimally Invasive Spinal Devices ... The European minimally invasive spinal implant ... Rapid growth of the MIS interbody and MIS ...
Cached Medicine Technology:Reportlinker Adds Global Injectable Drug Delivery Market (2010 - 2015) 2Reportlinker Adds Global Injectable Drug Delivery Market (2010 - 2015) 3Reportlinker Adds European Markets for Minimally Invasive Spinal Devices 2011 2
(Date:9/1/2015)... Toronto, Canada (PRWEB) , ... ... ... Technologies announce PRO Archiver for Alfresco, a next-generation customer communications archiving ... is built with market-leading technology from Crawford and helps organizations save millions ...
(Date:9/1/2015)... ... September 01, 2015 , ... Elizabeth Callahan, MD, founder ... the first in the area to offer RADIESSE® filler treatment for volume loss in ... prominence of tendons and veins in the hands, delivering smooth, natural-looking results that can ...
(Date:9/1/2015)... ... 2015 , ... A new episode of “Voices In America”, hosted by famous ... topic of arthritis. There are over 100 different types of arthritis. One of the ... in an effort to shed light on this important topic. , Anyone who is ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:8/31/2015)... Plano, TX (PRWEB) , ... September 01, 2015 ... ... other rehab professionals, today announced the release of ten hours of new premium ... for Board of Certification members. , Athletic Trainers certified before 2014 must complete ...
Breaking Medicine News(10 mins):Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2
... Ont., October 13, 2010 A new material similar to ... is showing promise as the next novel treatment for bleeding ... cent of adults, according to Hong Kong physician Dr. James ... on this world-first research at the 23rd International Course on ...
... 2010--Many women have trouble finding time to exercise in their ... in northern climates such as Canada, where the weather can ... exercise is critical to managing gestational diabetes, a growing problem ... , Researchers at St. Michael,s Hospital have proposed a novel ...
... The Gerontological Society of America (GSA) and New America Media ... Foundation Journalists in Aging Fellows Program . They represent a wide ... Today , Sing Tao Daily , the Minneapolis Star ... GSA,s Annual Scientific Meeting scheduled for November 19 ...
... stimulation (DBS) has proven to be a lifeline for ... disorder that can cause lack of control over movement, ... The procedure is used only for ... A neurosurgeon uses magnetic resonance imaging or computed tomography ...
... , TUESDAY, Oct. 12 (HealthDay News) -- Many patients ... cancers, although these tests are unlikely to provide any ... York City have found. Specifically, many patients diagnosed ... are still undergoing the ordeal of routine breast, prostate ...
... 2010 Tenofovir gel, a vaginal microbicide that has shown ... in a new trial looking at its safety and acceptability ... by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials ... evaluated further for its potential to prevent HIV among both ...
Cached Medicine News:Health News:Hemostatic powder stops bleeding ulcers: Doctor 2Health News:Can Wii help control gestational diabetes? 2Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 2Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 3Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 4Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 5Health News:Fellowship allows diverse reporters to cultivate public awareness of aging issues 6Health News:Researchers reach consensus on use of deep brain stimulation to treat Parkinson's 2Health News:Many With Terminal Cancer Still Getting Routine Screens 2Health News:Many With Terminal Cancer Still Getting Routine Screens 3Health News:Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use 2Health News:Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use 3Health News:Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use 4
The Equator Convective Warmer incorporates LEVEL 1's unique, patented, temperature control technology to ensure delivery of the desired therapy to the patient....
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Micro-Temp® II safely and consistently delivers a therapeutic level of localized heat using a pump, connecting hose and localized temperature therapy pad....
The Osom® Bvblue Test detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with Bacterial Vaginosis including Gardnerella, Bacteroides, Prevote...
Medicine Products: